Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Inflammation and Pain Post Injection of Ranibizumab vs. Aflibercept in Patients With Diabetic Macular Edema

NCT02363621 is registered in ClinicalTrials.gov with Arshad Khanani as lead sponsor.

NCT NCT02363621
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02363621 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Inflammation and Pain Post Injection of Ranibizumab vs. Aflibercept in Patients With Diabetic Macular Edema
Lead sponsor
Arshad Khanani
Phase
Phase 2
Overall status
Completed
Start date
January 31, 2015
Completion date
October 31, 2017
Enrollment
101 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetic macular edema